The termination of Ushercell trials in South Africa and Nigeria due to increased HIV infections among women is a setback for microbicide research.
Male circumcision, proven to reduce HIV risk by 60%, is now endorsed as an AIDS prevention strategy.
Studies show that treating genital herpes can also lower HIV transmission rates.
In Africa, where HIV is prevalent, primary health care is crucial.
Drug-resistant tuberculosis poses a significant threat, especially in HIV patients.
Additionally, research indicates a high prevalence of HIV-related dementia in sub-Saharan Africa, highlighting the urgent need for further study and treatment.
Malawi is working on an HIV/AIDS law to protect its population from
